Table 1 Number of WSIs present in the individual (2nd–4th columns), combined (5th-6th columns) and independent test (7th column) datasets where \({D}_{{cleo}}\), \({D}_{{fin}},{D}_{{tcga}}\), and \({D}_{{tiger}}\) correspond to the CLEOPATRA28, FinHER29, The Cancer Genome Atlas Breast Invasive Carcinoma cohort (TCGA-BRCA) and TIGER datasets while \({D}_{{mix\_FFPE}}\) and \({D}_{{mix\_all}}\) correspond to the combined datasets
Dataset | \({D}_{{cleo}}\) | \({D}_{{fin}}\) | \({D}_{{tcga}}\) | \({D}_{{mix\_FFPE}}({D}_{{cleo}}+{D}_{{fin}})\) | \({D}_{{mix\_all}}({D}_{{cleo}}+{D}_{{fin}}+{D}_{{tcga}})\) | \({D}_{{tiger}}\)(Test only) |
|---|---|---|---|---|---|---|
Tissue Type | FFPE | FFPE | FF | FFPE | FFPE + FF | FFPE |
Train | 477 | 416 | 444 | 893 | 1337 | – |
Validation | 120 | 104 | 112 | 224 | 336 | – |
Test | 150 | 131 | 139 | 281 | 420 | 82 |
